Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|
Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|---|---|---|---|---|---|---|---|
Q4 2024 | 26 | $4.04B | +$286M | -$272M | +$13.5M | AVGO, PEG, ARES, MS, ABBV | 13F-HR | 1/16/2025, 05:08 PM |
Q3 2024 | 25 | $3.98B | +$553M | -$91M | +$462M | AVGO, PEG, ABBV, ORI, UL | 13F-HR | 10/24/2024, 12:32 PM |
Q2 2024 | 26 | $3.4B | +$153M | -$103M | +$50M | AVGO, PEG, ABBV, COP, LAMR | 13F-HR | 8/13/2024, 05:15 PM |
Q1 2024 | 25 | $3.39B | +$209M | -$240M | -$31.3M | AVGO, ABBV, COP, LAMR, ARES | 13F-HR | 5/15/2024, 11:40 AM |
Q4 2023 | 27 | $3.18B | +$88.3M | -$74.4M | +$13.9M | AVGO, ARES, COP, ABBV, LAMR | 13F-HR | 1/9/2024, 02:48 PM |
Q3 2023 | 26 | $2.91B | +$78M | -$54.1M | +$23.9M | AVGO, COP, ABBV, ARES, EPD | 13F-HR | 10/4/2023, 02:49 PM |
Q2 2023 | 26 | $2.98B | +$147M | -$120M | +$27.7M | AVGO, ARES, PG, COP, LAMR | 13F-HR | 7/14/2023, 09:51 AM |
Q1 2023 | 25 | $2.87B | +$212M | -$247M | -$34.5M | AVGO, ABBV, PG, LAMR, GPC | 13F-HR | 4/13/2023, 08:12 AM |
Q4 2022 | 27 | $2.82B | +$120M | -$91.4M | +$28.7M | GPC, ABBV, AVGO, COP, PG | 13F-HR | 1/20/2023, 03:35 PM |
Q3 2022 | 28 | $2.5B | +$259M | -$158M | +$101M | GPC, COP, ABBV, EPD, KDP | 13F-HR | 10/13/2022, 11:55 AM |
Q2 2022 | 29 | $2.49B | +$250M | -$257M | -$7.7M | ABBV, GPC, JNJ, COP, EPD | 13F-HR | 7/12/2022, 04:08 PM |
Q1 2022 | 26 | $2.84B | +$166M | -$127M | +$39.5M | ABBV, AVGO, COP, ORI, PEG | 13F-HR | 4/19/2022, 03:34 PM |
Q4 2021 | 28 | $2.82B | +$295M | -$249M | +$46M | AVGO, ABBV, KEY, GPC, ORI | 13F-HR | 1/25/2022, 01:23 PM |
Q3 2021 | 28 | $2.51B | +$37.1M | -$20.8M | +$16.3M | KEY, ORI, AVGO, LAMR, IPG | 13F-HR | 10/14/2021, 01:28 PM |
Q2 2021 | 28 | $2.54B | +$185M | -$211M | -$25.6M | ORI, GPC, KEY, ABBV, LAMR | 13F-HR | 7/14/2021, 04:06 PM |
Q1 2021 | 29 | $2.44B | +$288M | -$254M | +$33.7M | ORI, GPC, KEY, STLD, AVGO | 13F-HR | 4/14/2021, 06:09 PM |
Q4 2020 | 29 | $2.17B | +$267M | -$252M | +$15.1M | KEY, AVGO, ABBV, GPC, ORI | 13F-HR | 1/26/2021, 12:11 PM |
Q3 2020 | 28 | $1.89B | +$343M | -$402M | -$58.9M | VZ, KEY, AVGO, QCOM, PEG | 13F-HR | 10/13/2020, 12:43 PM |
Q2 2020 | 36 | $1.87B | +$320M | -$377M | -$56.9M | CVX, T, VZ, JNJ, ABBV | 13F-HR | 7/15/2020, 08:59 AM |
Q1 2020 | 42 | $1.67B | +$550M | -$825M | -$275M | VZ, T, PFE, SNY, ABBV | 13F-HR | 5/11/2020, 12:23 PM |
Q4 2019 | 41 | $2.4B | +$135M | -$40.1M | +$95.3M | T, VZ, TGT, BCE, EPD | 13F-HR | 1/17/2020, 03:37 PM |
Q3 2019 | 37 | $2.22B | +$103M | -$276M | -$173M | T, VZ, TGT, BCE, EPD | 13F-HR | 10/16/2019, 11:03 AM |
Q2 2019 | 39 | $2.33B | +$249M | -$224M | +$24.4M | T, VZ, PFE, EPD, BCE | 13F-HR | 7/22/2019, 04:39 PM |
Q1 2019 | 38 | $2.24B | +$48.6M | -$149M | -$101M | VZ, T, EPD, TGT, PFE | 13F-HR | 4/12/2019, 04:23 PM |
Q4 2018 | 47 | $2.15B | +$393M | -$560M | -$168M | VZ, PFE, QCOM, T, BCE | 13F-HR | 1/18/2019, 04:14 PM |
Q3 2018 | 42 | $2.55B | +$121M | -$123M | -$1.87M | PFE, CSCO, T, QCOM, EPD | 13F-HR | 10/15/2018, 04:19 PM |
Q2 2018 | 39 | $2.46B | +$408M | -$551M | -$143M | T, STAY, EPD, PFE, CSCO | 13F-HR | 7/12/2018, 02:09 PM |
Q1 2018 | 42 | $2.59B | +$409M | -$359M | +$49.4M | RDSB, INTC, T, CSCO, STAY | Restatement | 4/18/2018, 05:09 PM |
Q4 2017 | 40 | $2.6B | +$255M | -$245M | +$9.83M | CSCO, RDSB, T, GM, PFE | 13F-HR | 1/31/2018, 04:06 PM |
Q3 2017 | 34 | $2.47B | +$159M | -$174M | -$15.1M | RDSB, T, CSCO, GM, STAY | 13F-HR | 10/23/2017, 03:55 PM |
Q2 2017 | 36 | $2.4B | +$360M | -$326M | +$33.4M | STAY, EPD, PFE, GM, T | 13F-HR | 7/27/2017, 04:54 PM |
Q1 2017 | 40 | $2.37B | +$449M | -$379M | +$69.5M | PFE, RDSB, GM, ETN, CSCO | 13F-HR | 4/26/2017, 11:47 AM |
Q4 2016 | 43 | $2.24B | +$157M | -$142M | +$15.2M | GM, RHP, T, KSS, HPT | 13F-HR | 1/27/2017, 01:18 PM |
Q3 2016 | 41 | $2.16B | +$246M | -$212M | +$34.3M | GM, CSCO, WY, ABBNY, HPT | 13F-HR | 10/20/2016, 04:08 PM |
Q2 2016 | 40 | $2.06B | +$261M | -$199M | +$61.5M | T, QCOM, RGC, AEO, GM | 13F-HR | 7/27/2016, 12:16 PM |
Q1 2016 | 38 | $1.98B | +$239M | -$195M | +$44.2M | T, ETN, BCE, PEG, RGC | 13F-HR | 5/2/2016, 10:33 AM |
Q4 2015 | 39 | $1.85B | +$227M | -$258M | -$31M | T, DOW, LAMR, VOD, GM | 13F-HR | 1/22/2016, 01:06 PM |
Q3 2015 | 41 | $1.81B | +$242M | -$214M | +$28.7M | T, BCE, VOD, DOW, LAMR | 13F-HR | 10/22/2015, 02:26 PM |
Q2 2015 | 41 | $1.98B | +$177M | -$40.8M | +$136M | T, DOW, VOD, ABBV, BCE | 13F-HR | 7/16/2015, 01:38 PM |
Q1 2015 | 40 | $1.9B | +$278M | -$211M | +$66.2M | DOW, BCE, T, PSO, ETN | 13F-HR | 4/30/2015, 06:38 AM |
Q4 2014 | 43 | $1.79B | +$344M | -$297M | +$47.8M | RHP, T, DOW, VET, SON | 13F-HR | 1/27/2015, 11:19 AM |
Q3 2014 | 45 | $1.67B | +$184M | -$219M | -$35.6M | T, RHP, PEG, INTC, GSK | 13F-HR | 10/31/2014, 07:59 AM |
Q2 2014 | 45 | $1.78B | +$272M | -$141M | +$131M | T, BTE, RHP, INTC, PEG | 13F-HR | 8/13/2014, 08:56 AM |
Q1 2014 | 41 | $1.56B | +$214M | -$170M | +$44M | T, BTE, PEG, RHP, COP | 13F-HR | 5/5/2014, 01:32 PM |
Q4 2013 | 42 | $1.47B | $0 | $0 | DOW, RHP, MRK, INTC, ABBV | 13F-HR | 1/27/2014, 11:53 AM |